Declines in Aarti Drugs' share price have been driven by a combination of macroeconomic headwinds, institutional selling pressures across mid-cap equities, and sector-specific challenges within the Active Pharmaceutical Ingredient (API) space. Margin pressures stemming from raw material cost volatility and temporary earnings deceleration relative to peak previous years have also prompted market valuation adjustments.